CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Samsung has been working on a noninvasive solution for optical continuous glucose monitoring, that could one day come to ...

After a long wait, Galaxy Watch devices could finally receive the non-invasive blood glucose monitoring feature.

The researchers found that 14 days of data from the virtual continuous glucose monitors had a similar ability to predict ...

In addition to the time spent in a safe blood-sugar range of 70 to 180 mg/DL, the researchers also found that other continuous glucose monitor readings also accurately predicted diabetes ...

Continuous glucose monitors provide diabetics with an invaluable data set for managing their blood sugar level ... Authority The holy grail would be a system as accurate, compact, and noninvasive ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

The global patient monitoring market size was valued at USD 55.60 billion in 2024 and is projected to reach from USD 59.66 billion in 2025 to USD 112.47 billion by 2033, growing at a CAGR of 7.3% ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...